We are live on ! Find out more
EXAS

Exact Sciences

Delisted

EXAS was delisted on the 20th of March, 2026.

182 hedge funds and large institutions have $1.93B invested in Exact Sciences in 2015 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 89 increasing their positions, 44 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

102% more repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 44

8% less funds holding

Funds holding: 198182 (-16)

16% less capital invested

Capital invested by funds: $2.31B → $1.93B (-$377M)

22% less call options, than puts

Call options by funds: $34.6M | Put options by funds: $44.4M

34% less first-time investments, than exits

New positions opened: 27 | Existing positions closed: 41

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
182
Holders Change
-16
Holders Change %
-8.08%
% of All Funds
4.85%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.05%
New
27
Increased
89
Reduced
44
Closed
41
Calls
$34.6M
Puts
$44.4M
Net Calls
-$9.81M
Net Calls Change
-$20.1M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$206M +$77.7M +3,064,102 +49%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$135M +$14.6M +574,100 +10%
Vanguard Group
3
Vanguard Group
Pennsylvania
$126M +$13.5M +530,913 +10%
William Blair & Company
4
William Blair & Company
Illinois
$125M +$15.2M +600,752 +12%
Invesco
5
Invesco
Georgia
$80.5M -$5.75M -226,509 -6%
GGHC
6
Gilder Gagnon Howe & Co
New York
$77.8M -$1.2M -47,309 -1%
First Trust Advisors
7
First Trust Advisors
Illinois
$76.7M +$22M +868,313 +33%
JPCCM
8
J&P (China) Capital Management
China
$68.3M
Primecap Management
9
Primecap Management
California
$55.6M +$127K +5,000 +0.2%
State Street
10
State Street
Massachusetts
$51M +$9.63M +379,477 +20%
BIT
11
BlackRock Institutional Trust
California
$50.8M +$2.53M +99,833 +5%
BFA
12
BlackRock Fund Advisors
California
$50.2M +$4.39M +173,197 +8%
JP Morgan Chase
13
JP Morgan Chase
New York
$43.7M +$12.2M +479,408 +32%
O
14
OrbiMed
New York
$39.2M
Artisan Partners
15
Artisan Partners
Wisconsin
$36.3M +$9.67M +381,295 +30%
Luther King Capital Management (LKCM)
16
Luther King Capital Management (LKCM)
Texas
$34.2M -$12.2M -481,250 -24%
TAM
17
Tiverton Asset Management
Delaware
$33M
PHS
18
PFM Health Sciences
California
$29.3M +$33.8M +1,331,742 New
CCM
19
Cupps Capital Management
Illinois
$27.8M -$4.28M -168,822 -12%
UBS AM
20
UBS AM
Illinois
$26.3M +$7.38M +291,100 +32%
Wells Fargo
21
Wells Fargo
California
$24.1M +$7.51M +296,199 +37%
ZCI
22
Zevenbergen Capital Investments
Washington
$23.4M +$26.9M +1,061,030 New
ACH
23
ArrowMark Colorado Holdings
Colorado
$23.3M +$7.35M +289,803 +38%
Northern Trust
24
Northern Trust
Illinois
$22.4M +$1.56M +61,386 +6%
WA
25
Wasatch Advisors
Utah
$21.5M -$19.2M -755,394 -44%

EXAS Hedge Fund Activity: Q1 2015 in Review

182 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2015, worth a combined $1.93B — down 16% from $2.31B a quarter earlier.

Sellers outnumbered buyers: 41 funds closed out of EXAS and 27 opened new positions — a net loss of 14 holders — while 44 trimmed existing stakes and 89 added.

The largest buyer was Capital Research Global Investors, adding an estimated $77.7M. The largest seller was Point72 Asset Management, cutting an estimated $58.9M.

  • 182 institutional investors held Exact Sciences (EXAS) as of Q1 2015, down from 198 in Q4 2014.
  • Funds reported $1.93B of Exact Sciences stock for Q1 2015, down 16% quarter-over-quarter.
  • 27 funds opened new Exact Sciences positions in Q1 2015 and 41 closed out, a net change of -14 holders.
  • The largest Exact Sciences buyer in Q1 2015 was Capital Research Global Investors, an estimated $77.7M added.
  • The largest Exact Sciences seller in Q1 2015 was Point72 Asset Management, an estimated $58.9M sold.

Based on aggregated 13F filings for Q1 2015.